81 related articles for article (PubMed ID: 356964)
1. Metabolic activation of 3-methylcholanthrene and its metabolites to products mutagenic to bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Thomas PE; Ryan D; Stoming TA; Thakker DR; Jerina DM; Conney AH
Cancer Res; 1978 Oct; 38(10):3398-404. PubMed ID: 356964
[No Abstract] [Full Text] [Related]
2. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
Schut HA; Thorgeirsson SS
Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
[No Abstract] [Full Text] [Related]
3. Metabolic activation of 3-methylcholanthrene: mutagenic and transforming activities of the 9,10-dihydrodiol.
Malaveille C; Bartsch H; Marquardt H; Baker S; Tierney B; Hewer A; Grover PL; Sims P
Biochem Biophys Res Commun; 1978 Dec; 85(4):1568-74. PubMed ID: 369566
[No Abstract] [Full Text] [Related]
4. Metabolic activation of dibenzo(a,h)anthracene and its dihydrodiols to bacterial mutagens.
Wood AW; Levin W; Thomas PE; Ryan D; Karle JM; Yagi H; Jerina DM; Conney AH
Cancer Res; 1978 Jul; 38(7):1967-73. PubMed ID: 350381
[No Abstract] [Full Text] [Related]
5. Metabolism of mutagenic amino-gamma-carbolines in tryptophan pyrolysates.
Kato R; Yamazoe Y; Ishii K; Mita S; Kamataki T; Sugimura T
Adv Exp Med Biol; 1981; 136 Pt B():997-1009. PubMed ID: 7046392
[No Abstract] [Full Text] [Related]
6. Mutagenicity of the dihydrodiols and bay-region diol-epoxides of benzo(c)phenanthrene in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Croisy-Delcey M; Ittah Y; Yagi H; Jerina DM; Conney AH
Cancer Res; 1980 Aug; 40(8 Pt 1):2876-83. PubMed ID: 6992991
[No Abstract] [Full Text] [Related]
7. Benz[j]aceanthrylene: a novel polycyclic aromatic hydrocarbon with bacterial mutagenic activity.
Sangaiah R; Gold A; Toney GE; Toney SH; Claxton L; Easterling R; Nesnow S
Mutat Res; 1983 Mar; 119(3):259-66. PubMed ID: 6338375
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of mutagenic tryptophan pyrolysis products by rat liver microsomes.
Ishii K; Yamazoe Y; Kamataki T; Kato R
Cancer Res; 1980 Jul; 40(7):2596-600. PubMed ID: 6771001
[TBL] [Abstract][Full Text] [Related]
9. Developmental pattern of 3-methylcholanthrene-inducible mutagenic activation of N-2-fluorenylacetamide, 2-fluorenamine, and 2,4-diaminoanisole in the rabbit.
Aune T; Dybing E; Thorgeirsson SS
J Natl Cancer Inst; 1980 Apr; 64(4):765-9. PubMed ID: 6928989
[TBL] [Abstract][Full Text] [Related]
10. Microsomal biotransformation of benzo[ghi]perylene, a mutagenic polycyclic aromatic hydrocarbon without a "classic" bay region.
Platt KL; Grupe S
Chem Res Toxicol; 2005 Apr; 18(4):700-10. PubMed ID: 15833030
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivatives.
Frei E; Pool BL; Plesch W; Wiessler M
IARC Sci Publ; 1984; (57):491-7. PubMed ID: 6398301
[TBL] [Abstract][Full Text] [Related]
12. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters.
Nohmi T; Mizokami K; Kawano S; Fukuhara M; Ishidate M
Jpn J Cancer Res; 1987 Feb; 78(2):153-61. PubMed ID: 3104258
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 6-methylbenz[a]anthracene by rat liver microsomes and mutagenicity of metabolites.
Mushtaq M; Fu PP; Miller DW; Yang SK
Cancer Res; 1985 Sep; 45(9):4006-14. PubMed ID: 3896475
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
Chiu PL; Yang SK
Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
[TBL] [Abstract][Full Text] [Related]
16. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
Czygan P; Greim H; Garro A; Schaffner F; Popper H
Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
[No Abstract] [Full Text] [Related]
17. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver.
Ong T; Mukhtar M; Wolf CR; Zeiger E
J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of mutagenic tryptophan pyrolysis products (Trp-P-1 and Trp-P-2) by a purified cytochrome P-450-dependent monooxygenase system.
Ishii K; Ando M; Kamataki T; Kato R; Nagao M
Cancer Lett; 1980 Jun; 9(4):271-6. PubMed ID: 6772296
[TBL] [Abstract][Full Text] [Related]
19. Androgen-dependent renal microsomal cytochrome P-450 responsible for N-hydroxylation and mutagenic activation of 3-methoxy-4-aminoazobenzene in the BALB/c mouse.
Degawa M; Miura S; Hashimoto Y
Cancer Res; 1990 May; 50(9):2729-33. PubMed ID: 2328499
[TBL] [Abstract][Full Text] [Related]
20. Immunological analysis of the roles of two major types of cytochrome P-450 in mutagenesis of compounds isolated from pyrolysates.
Watanabe J; Kawajiri K; Yonekawa H; Nagao M; Tagashira Y
Biochem Biophys Res Commun; 1982 Jan; 104(1):193-9. PubMed ID: 6803780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
